AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 82 filers reported holding AGILE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $319,000 | -56.7% | 1,523,758 | +1.1% | 0.00% | – |
| Q4 2021 | $736,000 | -47.9% | 1,507,654 | +2.5% | 0.00% | – |
| Q3 2021 | $1,413,000 | -18.8% | 1,470,260 | +12.3% | 0.00% | – |
| Q2 2021 | $1,740,000 | -83.6% | 1,308,650 | -74.3% | 0.00% | – |
| Q1 2021 | $10,604,000 | -27.9% | 5,098,282 | -0.5% | 0.00% | – |
| Q4 2020 | $14,699,000 | -5.3% | 5,121,965 | +0.3% | 0.00% | -100.0% |
| Q3 2020 | $15,517,000 | +8.6% | 5,104,426 | -0.6% | 0.00% | 0.0% |
| Q2 2020 | $14,282,000 | +510.1% | 5,137,173 | +308.1% | 0.00% | – |
| Q1 2020 | $2,341,000 | -2.1% | 1,258,808 | +31.6% | 0.00% | – |
| Q4 2019 | $2,390,000 | +1101.0% | 956,212 | +472.3% | 0.00% | – |
| Q3 2019 | $199,000 | -19.4% | 167,089 | -1.3% | 0.00% | – |
| Q2 2019 | $247,000 | +22.9% | 169,226 | +27.2% | 0.00% | – |
| Q1 2019 | $201,000 | +161.0% | 133,014 | -0.2% | 0.00% | – |
| Q4 2018 | $77,000 | +83.3% | 133,219 | +15.7% | 0.00% | – |
| Q3 2018 | $42,000 | -25.0% | 115,181 | +2.0% | 0.00% | – |
| Q2 2018 | $56,000 | -81.8% | 112,902 | -5.8% | 0.00% | – |
| Q1 2018 | $308,000 | +2.0% | 119,813 | +6.9% | 0.00% | – |
| Q4 2017 | $302,000 | -37.9% | 112,103 | +2.9% | 0.00% | – |
| Q3 2017 | $486,000 | +106.8% | 108,891 | +73.8% | 0.00% | – |
| Q2 2017 | $235,000 | -88.5% | 62,666 | -90.1% | 0.00% | – |
| Q1 2017 | $2,036,000 | +67766.7% | 635,231 | +108486.5% | 0.00% | – |
| Q4 2016 | $3,000 | -25.0% | 585 | 0.0% | 0.00% | – |
| Q3 2016 | $4,000 | 0.0% | 585 | 0.0% | 0.00% | – |
| Q2 2016 | $4,000 | +300.0% | 585 | +261.1% | 0.00% | – |
| Q1 2016 | $1,000 | – | 162 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|